All-cause failure following total hip arthroplasty (THA) for intracapsular neck of femur (NOF) fracture remains a concern, with revision potentially required for infection, dislocations or peri-prosthetic fracture (POPFF). Mid-term survivorship of the Lubinus SP-II composite beam anatomical femoral stem in trauma THA remains incompletely characterised. This study aimed to determine implant survivorship and incidence of all-cause revision. Over a 9-year period, between January-2017 and December-2025, 165 patients with intracapsular neck-of-femur fractures presenting to NHS-Fife underwent THA in accordance with National Institute for Health and Care Excellence (NICE) guidelines. All procedures utilised the Lubinus SP-II composite beam anatomical femoral stem. Patient demographics including age, sex, address were collected prospectively in a hip fracture database. Medical records and radiographs were reviewed at a mean follow-up of 3.87 years to identify periprosthetic fracture, dislocation, infection, and revision surgery. A total of 165 patients underwent THA for intracapsular NOF fracture during the study period. The mean age was 67.2 years (range 50–84), with 123 females (74.7%) and 42 males (25.3%). Median time from admission to surgery was 2 days (IQR 1–3), and median length of stay was 7 days (IQR 6–9). Femoral component revision-free survival was 98.8% (95% CI 95.7–99.7%) at a mean follow-up of 3.87 years; two patients required revision of the femoral component, both for prosthetic joint infection. Overall, five patients underwent revision surgery (3.0%, 95% CI 1.3–6.9), comprising two revisions for infection and three revision procedures for recurrent dislocation without revision of the femoral stem. No POPFF were recorded (0/165). The Lubinus SP II composite beam femoral stem demonstrated excellent mid-term survivorship with low all-cause revision rates in patients undergoing THA for intracapsular neck of femur fractures. No postoperative periprosthetic femoral fractures were observed in this cohort.
No takes yet. Share an insight, caveat, or question.
Toru et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: